These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21288262)

  • 1. Survival in a large cohort of Greek patients with transfusion-dependent beta thalassaemia and mortality ratios compared to the general population.
    Ladis V; Chouliaras G; Berdoukas V; Chatziliami A; Fragodimitri C; Karabatsos F; Youssef J; Kattamis A; Karagiorga-Lagana M
    Eur J Haematol; 2011 Apr; 86(4):332-8. PubMed ID: 21288262
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Longitudinal study of survival and causes of death in patients with thalassemia major in Greece.
    Ladis V; Chouliaras G; Berdousi H; Kanavakis E; Kattamis C
    Ann N Y Acad Sci; 2005; 1054():445-50. PubMed ID: 16339695
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survival and complications in thalassemia.
    Borgna-Pignatti C; Cappellini MD; De Stefano P; Del Vecchio GC; Forni GL; Gamberini MR; Ghilardi R; Origa R; Piga A; Romeo MA; Zhao H; Cnaan A
    Ann N Y Acad Sci; 2005; 1054():40-7. PubMed ID: 16339650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of thalassemia treated with conventional therapy.
    Borgna-Pignatti C; Zurlo MG; DeStefano P; Boffa C; DeSanctis V; DiPalma A; DiGregorio L; Melevendi C; Piga A; Sabato V
    Bone Marrow Transplant; 1993; 12 Suppl 1():2-4. PubMed ID: 8374554
    [No Abstract]   [Full Text] [Related]  

  • 5. Morbidities and mortality in transfusion-dependent Beta-thalassemia patients (single-center experience).
    Mokhtar GM; Gadallah M; El Sherif NH; Ali HT
    Pediatr Hematol Oncol; 2013 Mar; 30(2):93-103. PubMed ID: 23301991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quality of life and survival of patients with beta-thalassemia major.
    Cao A
    Haematologica; 2004 Oct; 89(10):1157-9. PubMed ID: 15477196
    [No Abstract]   [Full Text] [Related]  

  • 7. The influence of treatment in specialized centers on survival of patients with thalassemia major.
    Forni GL; Puntoni M; Boeri E; Terenzani L; Balocco M
    Am J Hematol; 2009 May; 84(5):317-8. PubMed ID: 19396857
    [No Abstract]   [Full Text] [Related]  

  • 8. Survival, mortality, and complications in patients with beta-thalassemia major in northern Taiwan.
    Chern JP; Su S; Lin KH; Chang SH; Lu MY; Jou ST; Lin DT; Ho WL; Lin KS
    Pediatr Blood Cancer; 2007 May; 48(5):550-4. PubMed ID: 16972241
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The survival analysis of beta thalassemia major patients in South East of Iran.
    Roudbari M; Soltani-Rad M; Roudbari S
    Saudi Med J; 2008 Jul; 29(7):1031-5. PubMed ID: 18626536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Survival in medically treated patients with homozygous beta-thalassemia.
    Olivieri NF; Nathan DG; MacMillan JH; Wayne AS; Liu PP; McGee A; Martin M; Koren G; Cohen AR
    N Engl J Med; 1994 Sep; 331(9):574-8. PubMed ID: 8047081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-transferrin-bound labile plasma iron and iron overload in sickle-cell disease: a comparative study between sickle-cell disease and beta-thalassemic patients.
    Koren A; Fink D; Admoni O; Tennenbaum-Rakover Y; Levin C
    Eur J Haematol; 2010 Jan; 84(1):72-8. PubMed ID: 19732137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival and complications in patients with haemoglobin E thalassaemia in Sri Lanka: a prospective, longitudinal cohort study.
    Premawardhena AP; Ediriweera DS; Sabouhanian A; Allen A; Rees D; de Silva S; Perera W; Katugaha N; Arambepola M; Yamashita RC; Mettananda S; Jiffry N; Mehta V; Cader R; Bandara D; St Pierre T; Muraca G; Fisher C; Kirubarajan A; Khan S; Allen S; Lamabadusuriya SP; Weatherall DJ; Olivieri NF
    Lancet Glob Health; 2022 Jan; 10(1):e134-e141. PubMed ID: 34843671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hb E beta +-thalassaemia in west Malaysia: clinical features in the most common beta-thalassaemia mutation of the Malays [IVS 1-5 (G-->C)].
    George E; Wong HB
    Singapore Med J; 1993 Dec; 34(6):500-3. PubMed ID: 8153710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth velocity in transfusion dependent prepubertal thalassemia patients: results from a thalassemia center in Malaysia.
    Hamidah A; Arini MI; Zarina AL; Zulkifli SZ; Jamal R
    Southeast Asian J Trop Med Public Health; 2008 Sep; 39(5):900-5. PubMed ID: 19058587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of hydroxyurea on the transfusion requirements in patients with severe HbE-beta-thalassaemia: a genotypic and phenotypic study.
    Italia KY; Jijina FF; Merchant R; Panjwani S; Nadkarni AH; Sawant PM; Nair SB; Ghosh K; Colah RB
    J Clin Pathol; 2010 Feb; 63(2):147-50. PubMed ID: 20154037
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiac related death in thalassaemia major: time trend and risk factors in a large Greek Unit.
    Chouliaras G; Yiannoutsos CT; Berdoukas V; Ladis V
    Eur J Haematol; 2009 May; 82(5):381-7. PubMed ID: 19141117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Red cell immunization in beta thalassaemia major.
    Bhatti FA; Salamat N; Nadeem A; Shabbir N
    J Coll Physicians Surg Pak; 2004 Nov; 14(11):657-60. PubMed ID: 15530273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The changing profile of homozygous beta-thalassemia: demography, ethnicity, and age distribution of current North American patients and changes in two decades.
    Pearson HA; Cohen AR; Giardina PJ; Kazazian HH
    Pediatrics; 1996 Mar; 97(3):352-6. PubMed ID: 8604269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unrelated bone marrow transplantation for beta-thalassemia patients: The experience of the Italian Bone Marrow Transplant Group.
    La Nasa G; Argiolu F; Giardini C; Pession A; Fagioli F; Caocci G; Vacca A; De Stefano P; Piras E; Ledda A; Piroddi A; Littera R; Nesci S; Locatelli F
    Ann N Y Acad Sci; 2005; 1054():186-95. PubMed ID: 16339665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Response to hydroxyurea therapy in beta-thalassemia.
    Koren A; Levin C; Dgany O; Kransnov T; Elhasid R; Zalman L; Palmor H; Tamary H
    Am J Hematol; 2008 May; 83(5):366-70. PubMed ID: 18181203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.